Law360 has named life sciences partner Ray Grant a “Rising Star” in the Life Sciences category. The annual list recognizes attorneys under 40 whose legal accomplishments distinguish them among their peers.
Ray has served as lead counsel on life sciences transactions totaling more than $5 billion in aggregate value across four continents. These transactions include Bain Capital portfolio company Tanabe Pharma Corporation’s $2.5 billion sale of global rights to its neurodegenerative disease therapy RADICAVA business to Shionogi; the creation of Beeline Medicines, which launched with five Bristol Myers Squibb immunology assets and a $300 million financing commitment led by Bain Capital; and the formation of weight management biotechnology company Kailera Therapeutics and $400 million Series A financing. Ray’s pragmatic, business-oriented approach and ability to lead intricate, fast-moving transactions have distinguished him as a trusted adviser on complex, high-stakes life sciences matters.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.